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摘    要 
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摘   要 
 
糖尿病肾病(diabetic nephropathy, DN)是糖尿病慢性并发症(DCC)中的一种，













诱导蛋白激酶(serum and glucocorticoid inducible protein kinase, SGK) 是一种新
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Abstract 
Diabetic nephropathy, DN is one of the Diabetic chronic complications, it is the 
main reason for disability and death caused by diabetes mellitus (DM). According to 
statistics, 30 percent to 40 percent of the type diabetes patients and 40 percent of Ⅰ
the type  diabetes patients with diabetic nephropathy, there may be proteinuria Ⅱ
hypertension at the first to the development of nephrotic syndrome, leading to renal 
failure and death, the 3 year survival rate of DN is only about 50 percent. Glucose 
metabolism in the polyol pathway is closely related to diabetic chronic complications 
such as diabetic vascular disease, kidney disease, retinopathy and peripheral 
neuropathy. And aldose reductase is a polyol sugar metabolism speed of the slip road, 
therefore, increased AR activity may be one of the main reasons leading to DN. 
Aldose reductase is one of the two enzymes composed of polyol pathway,   
which is also the speed limit enzyme of the glucose metabolism , responsible for the 
reduction of glucose to sorbitol with the help of supporting factor NADPH. In renal, 
AR is highly expressed at inner medulla, in order to convert glucose to sorbitol. The 
latter is the important organic osmolyte in kidney, used to protect the renal collection 
tubule cell out of the damage caused by high osmotic pressure. 
Sustained high blood glucose is the major risk factors lesd to diabetic 
nephropathy, high blood glucose can lead mesangial matrix expansion and mesangial 
cell proliferation through certain serine / threonine protein kinase .Serum and 
glucocorticoid inducible protein kinase, SGK is a novel member of the 
serine/threonine protein kinase gene family，which has SGK1, SGK2 and SGK3 3 
subtypes. Unlike the vast majority of protein kinases, which are predominantly 
regulated at the enzymatic level by posttranslational phosphorylation and 
dephosphorylation, the transcript expression, activity and subcellular localization of 
SGK1 can be acutely controlled by a diverse set of stimuli. SGK is an important focal 
point of intracellular cross-talk to control many cellular processes, including cell 
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apoptotic responses. The expression of SGK1 mRNA in diabetic patients` kidney was 
significantly higher than normal, thus SGK1 may be involved in the incidence of 
diabetic nephropathy. 
The sodium/potassium/2 chloride cotransporter type 2 (NKCC2) is located in the 
apical membrane of the thick ascending limb (TAL) and macula densa,which has 
NKCC2A, NKCC2B and NKCC2F 3 subtypes.NKCC2 is involved in the active 
transport of sodium from the lumen into the basolateral fluid. As a result, salt 
accumulates in the medullary interstitium. Hypertonicity in the medullary interstitium 
created by the high concentration of salt is an important local signal for the renal 
medulla. 
However, the research on the relation between AR、NKCC2 and SGK1 has not 
reported so far. We constructed a adenovirus with mouse AR、NKCC2 gene and 
infected into mIMCD3 cells, then research on the relationship between AR 、NKCC2 
and SGK1 using western blot and immunocytochemical technology. The results 
showed that: in vitro ,after over- expression of the AR, the expression of SGK1 has 
been significantly improved in mIMCD3 cells. In addition, by means of 
immunohistochemistry ,we also found that the SGK1 expression decreased 
significantly in the kidney of AR-knockout mouse, and there was some restoration of 
SGK1 expression in the kidney of AR bitransgenic mice. Note that the expression of 
SGK1 in renal cells is positive regulated by AR.  
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1  前言 





















括: 1.多元醇糖代谢途径; 2.非酶催化蛋白质糖基化 (nonenzymatic glycation of 
proteins); 3.葡萄糖诱导产生的活性氧基团的氧化应激 (oxidative stress due to 
glucose-induced generation of reactive oxygen species); 4.二酰甘油从头合成导致蛋
白激酶C的激活 (de novo synthesis of diacylglycerol leading to protein kinase C 
activation); 以及 5.氨基己糖 (hexosamine) 合成途径。值得注意是,这几个途径并
非只能单独或分别运行,它们可顺序运行或同时运行。多元醇糖代谢途径假说的
重点在于, 在高血糖下, 大量的葡萄糖通过多元醇糖代谢支路被消化; 这一过程




























梨醇含量却没明显变化。在肾小球中, 系膜细胞(mesangial cells) [10]和内皮细胞










正NADH/ NAD 比值异常。(2) 有助于减轻细胞外高渗状态。 
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相关[25]。 
多元醇糖代谢通路由 AR 及山梨醇脱氢酶（sorbitol dehydrogenase，SDH）
共同构成，AR 是多元醇通路的关键限速酶。该通路由两步的生化反应组成，第






萄糖反应元件 GRE 及渗透压反应元件（osmotic response elements，ORE）被激
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